Tuoxin Pharmaceutical Group Co.,Ltd. (SZSE: 301089)
Health Care · Pharmaceuticals · CN
CN¥24.20
-4.72% today · -31.4% 1Y
Tuoxin Pharmaceutical Group Co.,Ltd. (SZSE: 301089) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $455.55M.
Over the last twelve months the share price has lost 31.4%, trading between 19.33 and 36.34.
Tweenvest scores Tuoxin Pharmaceutical Group Co.,Ltd. across four factors: quality 66/100, value 45/100, growth 0/100. Its strongest factor is quality.
301089 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $455.55M
- Revenue (TTM)
- $54.20M
- P/E
- —
- EPS
- -0.59
- Dividend yield
- —
- Beta (5Y)
- -0.61
- 52-week high
- CN¥36.34
- 52-week low
- CN¥19.33
- Avg volume (3M)
- —
- Shares outstanding
- 126.54M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.